Sisäänkirjautuminen

Cavalla, David

Off-label Prescribing: Justifying Unapproved Medicine

Cavalla, David - Off-label Prescribing: Justifying Unapproved Medicine, e-kirja

48,05€

E-kirja, ePUB, Adobe DRM-suojattu
ISBN: 9781118912041
DRM-rajoitukset

Tulostus65 sivua ja lisä sivu kertyy joka 12. tunti, ylärajana 65 sivua
Kopioi leikepöydälle5 poimintoa

Today’s medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients.

But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview.

Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, ‘indication’) being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice.

The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.

Avainsanat: Medicine
Medical practice
Pharmacuetical
Clinical
Pharmacology
Drug Development
Drug regulation
Government
Biopharmaceutics
, Medicine
Medical practice
Pharmacuetical
Clinical
Pharmacology
Drug Development
Drug regulation
Government
Biopharmaceutics
, Medicine
Medical practice
Pharmacuetical
Clinical
Pharmacology
Drug Development
Drug regulation
Government
Biopharmaceutics
, Drug Formulation & Delivery

Tekijä(t)
Julkaisija
John Wiley and Sons, Inc.
Julkaisuvuosi
2015
Kieli
en
Painos
1
Sivumäärä
216 sivua
Kategoria
Eksaktit luonnontieteet
Tiedostomuoto
E-kirja
eISBN (ePUB)
9781118912041
Painetun ISBN
9781118912065

Samankaltaisia e-kirjoja